---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-045344"
form_type: "8-K"
ticker: "LTRN"
cik: "0001763950"
company_name: "Lantern Pharma Inc."
filed_at: "2026-10-01T20:01:23+00:00"
generated_at: "2026-10-12T14:21:09.281045+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lantern Pharma gets Nasdaq notice: MVLS under $35M for 30 days, 180 days to regain compliance

## Summary
- Nasdaq notice dated September 25, 2026: market value of listed securities (MVLS) fell below the $35,000,000 minimum for 30 consecutive business days.
- Company also does not meet Nasdaq Listing Rules 5550(b)(1) and 5550(b)(3), per the notice.
- Has until March 24, 2027 (180 calendar days) to regain compliance under Listing Rule 5810(c)(3)(C).
- To cure via MVLS, LTRN stock must close at $35,000,000 or more for a minimum of 10 consecutive business days.
- If compliance is not regained, the company expects Nasdaq to notify it that its securities are subject to delisting from the Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001493152-26-045344
- form_type: 8-K
- ticker: LTRN
- cik: 0001763950
- company_name: Lantern Pharma Inc.
- filed_at: 2026-10-01T20:01:23+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1763950/000149315226045344/0001493152-26-045344-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1763950/000149315226045344/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-045344
- JSON: https://secwatch.observer/filing/0001493152-26-045344.json
- Plain text: https://secwatch.observer/filing/0001493152-26-045344.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.